Back to Search
RUTH RUPRECHT, M.D., PH.D.
M.D., PH.D.
Specialist
NPI: 1730210782Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
53666(MA)
Research & Publications (20)
Antibody protection: passive immunization of neonates against oral AIDS virus challenge.
PMID 12850342·Vaccine·2003
6-review
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodies.
PMID 11642027·Transfus Clin Biol·2001
6-review
Passive immunization with human neutralizing monoclonal antibodies against HIV-1 in macaque models: experimental approaches.
PMID 19252837·Methods Mol Biol·2009
7-preclinical
Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.
PMID 19019970·J Virol·2009
7-preclinical
CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acids.
PMID 19468063·J Exp Med·2009
7-preclinical
A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression.
PMID 19609201·AIDS·2009
4-observational
Generation of recombinant vaccinia viruses via green fluorescent protein selection.
PMID 19182996·DNA Cell Biol·2009
8-other
Pathogenic infection of Macaca nemestrina with a CCR5-tropic subtype-C simian-human immunodeficiency virus.
PMID 19602283·Retrovirology·2009
7-preclinical
Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: prolonged survival.
PMID 19201387·Vaccine·2009
7-preclinical
Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.
PMID 18648516·PLoS Negl Trop Dis·2008
7-preclinical
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.
PMID 18480433·J Virol·2008
8-other
Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing.
PMID 19081789·PLoS One·2008
7-preclinical
SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
PMID 18928523·Retrovirology·2008
7-preclinical
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.
PMID 18367229·Virology·2008
6-review
Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys.
PMID 17854955·Vaccine·2007
7-preclinical
Coinfection with Schistosoma mansoni reactivates viremia in rhesus macaques with chronic simian-human immunodeficiency virus clade C infection.
PMID 17283092·Infect Immun·2007
7-preclinical
Dendritic cell-based vaccine strategy against human immunodeficiency virus clade C: skewing the immune response toward a helper T cell type 2 profile.
PMID 17425430·Viral Immunol·2007
7-preclinical
Efficacy of a multigenic protein vaccine containing multimeric HIV gp160 against heterologous SHIV clade C challenges.
PMID 17721091·AIDS·2007
7-preclinical
Passive immunization as tool to identify protective HIV-1 Env epitopes.
PMID 18045119·Curr HIV Res·2007
6-review
Time dependence of protective post-exposure prophylaxis with human monoclonal antibodies against pathogenic SHIV challenge in newborn macaques.
PMID 16996554·Virology·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, DANA-FARBER CANCER INSTITUTE, JFB 809
BOSTON, MA 02115 - Phone
- (617) 632-3719
Quick Facts
- NPI
- 1730210782
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile